Form 8-K - Current report:
SEC Accession No. 0001193125-25-096909
Filing Date
2025-04-25
Accepted
2025-04-25 16:21:12
Documents
14
Period of Report
2025-04-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d807929d8k.htm   iXBRL 8-K 26923
2 EX-10.1 d807929dex101.htm EX-10.1 24672
  Complete submission text file 0001193125-25-096909.txt   183251

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrca-20250422.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20250422_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20250422_pre.xml EX-101.PRE 11262
16 EXTRACTED XBRL INSTANCE DOCUMENT d807929d8k_htm.xml XML 3613
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 25874440
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)